Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients

http://www.sanofi.us

PARIS and TARRYTOWN, N.Y., May 22, 2017 /PRNewswire/ — Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of Kevzara® (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA)…

May 23, 2017 at 03:19AM

http://ift.tt/2qPXeAg

from

http://ift.tt/2qPXeAg